In recent years, with the daily growth of the pharmaceutical and biological market and the increasing demand for domestic medicine, pharmaceutical equipment has also ushered in the industry’s requirements for the development of more intelligent, automated, and integrated pharmaceutical equipment During the period of rapid development, considerable progress has been made; the market continues to expand and technology continues to upgrade.
According to the author’s understanding, under the influence of the new policy environment, new product launches, new international competition and other factors, domestic and foreign pharmaceutical companies have begun to adjust the company’s product layout and enrich the product line based on external and internal factors. Adapt to policy and market change
As the so-called “everything is prosperous, everything is lost”, the pharmaceutical equipment industry, as the upstream industry of the pharmaceutical industry, is closely related to the development of the pharmaceutical industry. Faced with the general trend of industry reform, pharmaceutical equipment companies are in order to better meet the energy-saving, efficiency-increasing and green environmental protection of pharmaceutical companies. It is necessary to use high-quality pharmaceutical equipment as support to meet the various production needs of pharmaceutical companies.
In recent years, the vigorous development trend of China's pharmaceutical industry is unstoppable. For example, the market size of the biopharmaceutical industry in 2019 has exceeded 350 billion yuan. However, from the perspective of the entire pharmaceutical industry chain, there are still weak links. Among them, the problem of relying on imports for high-end equipment in the upstream is particularly prominent. It is reported that most of the domestic biopharmaceutical equipment share is currently occupied by European, American and Japanese companies. The mid-to-high-end market for domestic equipment is absent, and the overall innovation capability of the industry is not high.
In this regard, the industry pointed out that the cost of imported pharmaceutical equipment is often very high, which makes the high-end pharmaceutical equipment of domestic pharmaceutical companies vulnerable to control. Therefore, in the context of the continuous development of the pharmaceutical industry, domestic pharmaceutical equipment companies need to find ways to break the "stuck neck" bottleneck to create cost-effective pharmaceutical equipment for users to meet the production needs of pharmaceutical companies.
Increasing competition in the industry market
At present, after decades of development and accumulation, my country's pharmaceutical equipment industry has gradually formed a group of pharmaceutical equipment manufacturers with strong R&D capabilities, independent intellectual property rights, and strong competitiveness in the mid-to-high-end market.
However, in the face of the growing market year by year and the opportunities brought by the Internet, competition in the pharmaceutical equipment industry has become more and more fierce, with high product overlap and low-price wars. There are many problems due to the low industry threshold. The influx of inferior products into the market has also led to more and more inferior competition. In this context, how to improve the market competitiveness of enterprises has become a difficult problem.
How the pharmaceutical equipment industry responds to challenges
How should the pharmaceutical equipment industry deal with these challenges? The industry believes that the first step should be to innovate pharmaceutical equipment and pharmaceutical processes. In recent years, pharmaceutical companies have become increasingly demanding on pharmaceutical technology, and low-end pharmaceutical equipment with weak research and development capabilities that cannot meet the requirements is being eliminated at an accelerated pace. In this context, the pharmaceutical equipment industry needs innovative pharmaceutical equipment and pharmaceutical processes to meet the needs of pharmaceutical companies for efficiency, environmental protection, and safety.
In addition, the pharmaceutical equipment industry also needs to strengthen personnel training and cutting-edge technology research. With the continuous development and maturity of the pharmaceutical industry, it is often difficult for personnel with professional skills and abilities not up to standard to help pharmaceutical equipment companies to innovate and develop, and they may even become "blockers" in the development of the company. Therefore, the pharmaceutical equipment industry needs to strengthen the training of professional talents and inject new impetus into the innovation and development of enterprises, thereby driving the high-quality development of the pharmaceutical industry.